Physician profile
Emily L Exten
NPI 1205051141
$6,040.17
in general payments reported to CMS, 2019-2025
7 companies · $30.89 in 2025
The $30.89 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $720 · 2020: $14.51 · 2021: $2,491 · 2022: $516 · 2023: $14.84 · 2024: $2,253 · 2025: $30.89.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,810 · Food and Beverage: $488.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,810.41 |
| Food and Beverage | $487.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $3,397.82 | 2019-2024 | |
| Cdc Medical LLC | $1,164.91 | 2019-2021 | |
| Rock Medical Orthopedics, INC. | $703.42 | 2024 | |
| Smith+Nephew, INC. | $480.99 | 2019-2025 | Stravix Mesh |
| Stryker Corporation | $206.23 | 2019-2024 | Citrefix, Ortholoc 3di, Prostep Mica |
| Depuy Synthes Sales INC. | $44.97 | 2021 | |
| Bioventus LLC | $41.83 | 2023-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Exten listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.